Back to search
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tolvaptan, ATC G04BX21
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPublished on Mar 15, 2026
490 days left
GermanyDescription
Conclusion of non-exclusive rebate agreements pursuant to §§ 130a para. 8/130c para. 1 SGB V for medicinal products with the aforementioned active substance within the period from 01.05.2026 to 30.04.2028 with the possibility of concluding the contract at any time (open-house model). In the open-house procedure, medicinal products according to the BfArM list pursuant to § 35 para. 5a SGB V (paediatric medicinal products) are excluded.
CPV codes
Pharmaceutical products
Documents & submission
AI summary
Sign in for an AI summaryContains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
KKH Kaufmännische KrankenkasseGermanyPharmaceutical productsDeadline in 26,728 daysPublished on Oct 26, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – 1/DLII6/VM153 - RV Delta-Xpress-Fertigschienen, divers
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyMedical equipments, pharmaceuticals and personal care productsDeadline in 7 daysPublished on Oct 26, 2026
Germany – Medical consumables – 1/DLII6/VM110_RV_Infusionssystem
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyMedical consumablesDeadline in 34 daysPublished on Oct 26, 2026
Germany – Gas-therapy and respiratory devices – Beatmung Neonatologie Klinikum Oldenburg
Klinikum Oldenburg AöRGermanyGas-therapy and respiratory devicesDeadline in 30 daysPublished on Oct 26, 2026